Back to search
FDAFDA · Food and drugs·Recall number Z-1891-2024

Tri-Staple 2.0 Black Reinforced Intelligent Reload- Applications in abdominal, gynecologic, pediatric and thoracic surgery for resection, transection of tissue and creation of anastomosis Model: SIGTRSB60AXT

Published June 5, 2024 · Recall initiated: April 15, 2024

Summary

FDA records medical device Class II recall Z-1891-2024, published June 5, 2024 and initiated April 15, 2024. Recalling firm: Covidien, LP; Status: Ongoing; Reported quantity: 1681 units; Lot: GTIN: 10884521717633 20884521717630 Lot #: N3G1372Y. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Potential damage to the cartridge can result in poor staple formation and/or incomplete staple line, may cause a delay in surgery

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Covidien, LP
Distributor
Worldwide - US Nationwide distribution in the state of NJ and the countries of Australia, Japan, New Zealand, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand.
Lot
GTIN: 10884521717633 20884521717630 Lot #: N3G1372Y
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Tri-Staple 2.0 Black Reinforced Intelligent Reload- Applications in abdominal, gynecologic, pediatric and thoracic surgery for resection, transection of tissue and creation of anastomosis Model: SIGTRSB60AXT recalled?

Yes. FDA published recall Z-1891-2024 on June 5, 2024. Reported hazard: Potential damage to the cartridge can result in poor staple formation and/or incomplete staple line, may cause a delay in surgery

What should I do if I have this product?

Voluntary: Firm initiated · Letter